Univerzita Karlova v Praze / Charles University in Prague

University / College

Location: Praha / Prague / Prag, Czech Republic (CZ)

ISNI: 000000041937116X

ROR: https://ror.org/024d6js02

Show on Map:

Publications

(458)

Research Grants

(2)

Early cephalopod evolution clarified through Bayesian phylogenetic inference (2022) Pohle A, Kroeger B, Warnock R, King AH, Evans DH, Aubrechtova M, Cichowolski M, et al. Journal article Treatment and Disease Characteristics of Chronic Myeloid Leukemia in Blast Crisis: The European Leukemianet Blast Crisis Registry (2022) Brioli A, Lomaia E, Fabisch C, Sacha T, Klamova H, Morozova E, Golos A, et al. Conference contribution Polarized x-rays constrain the disk-jet geometry in the black hole x-ray binary Cygnus X-1 (2022) Krawczynski H, Muleri F, Dovčiak M, Veledina A, Rodriguez Cavero N, Svoboda J, Ingram A, et al. Journal article Editorial: Osteoarticular-immunological interplay in response to disease and therapy (2022) Deloch L, Filkova M, Tomcik M Journal article Desmin Knock-Out Cardiomyopathy: A Heart on the Verge of Metabolic Crisis (2022) Elsnicova B, Hornikova D, Tibenska V, Kolar D, Tlapakova T, Schmid B, Mallek M, et al. Journal article Towards a consistent model of the hot quadruple system HD 93206=QZ Carinae (2022) Mayer P, Harmanec P, Zasche P, Broz M, Catalan-Hurtado R, Barlow BN, Frondorf W, et al. Journal article Towards a consistent model of the hot quadruple system HD 93206=QZ Carin ae II. N-body model (2022) Broz M, Harmanec P, Zasche P, Catalan-Hurtado R, Barlow BN, Frondorf W, Wolf M, et al. Journal article Giant quadratic magneto-optical response of thin Y3Fe5 O12 films for sensitive magnetometry experiments (2022) Schmoranzerova E, Ostatnicky T, Kimak J, Kriegner D, Reichlova H, Schlitz R, Badura A, et al. Journal article Non-apoptotic FAS signaling controls CD40-dependent mTOR activation and balances extrafollicular versus germinal center fate in human B cells (2022) Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Bakardjieva M, Lorenzetti R, et al. Conference contribution Abatacept Significantly Reduces Subclinical Inflammation During Treatment (6 Months), This Persists After Discontinuation (12 Months), Resulting in a Delay in the Clinical Development of RA in Patients at Risk of RA (The ARIAA Study) (2022) Rech J, Kleyer A, Ostergaard M, Hagen M, Mendez LV, Tascilar K, Krönke G, et al. Conference contribution

‹ 1 ... 3 4 5 6 7 ... 46 ›